QA: Viatris Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001792044_2022_Viatris_Inc.pdf

Logs

info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Revenues', 'missing_ratio': 0.004081151479768267, 'aggregate_val': 17886300000, 'exp_sum': 17813600000, 'exp_to_value': {'remainder_Revenues': 17813600000}}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001792044, Viatris Inc

  xvar xval
0 AssetsCurrent 10,902,900,000
1 IntangibleAssetsNetIncludingGoodwill 38,247,900,000
2 PropertyPlantAndEquipmentNet 3,188,600,000
3 remainder_Assets 2,503,400,000
4 LiabilitiesCurrent 9,884,400,000
5 LiabilitiesNoncurrent 21,650,700,000
6 remainder_Liabilities 2,815,000,000
7 CostOfGoodsAndServicesSold 12,310,800,000
8 SellingGeneralAndAdministrativeExpense 4,529,200,000
9 ResearchAndDevelopmentExpense 751,100,000
10 remainder_Expenses 1,570,100,000
11 remainder_Revenues 17,886,300,000
12 remainder_NetIncome 5,800,000
13 remainder_ComprehensiveNetIncome -886,300,000
  yvar yval
0 Assets 54,842,800,000
1 Liabilities 34,350,100,000
2 Expenses 19,161,200,000
3 Revenues 17,886,300,000
4 StockholdersEquity 20,492,700,000
5 NetIncome -1,269,100,000
6 ComprehensiveNetIncome -1,712,250,000
7 BaseVar 63,566,250,000
8 EconomicCapitalRatio 0.752

Edgar->Model Mapping

Feature Distribution

Change over Time